Exact Mass: 343.0957

Exact Mass Matches: 343.0957

Found 111 metabolites which its exact mass value is equals to given mass value 343.0957, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DIBOA-Glc

4-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


Isolated from seedlings of rye (Secale cereale), and sweet corn (Zea mays) and seeds of Acanthus mollis. DIBOA-Glc is found in many foods, some of which are rye, fats and oils, corn, and cereals and cereal products. DIBOA-Glc is found in cereals and cereal products. DIBOA-Glc is isolated from seedlings of rye (Secale cereale), and sweet corn (Zea mays) and seeds of Acanthus mollis.

   

Violacein

Violacein; 3-(1,2-dihydro-5-(5-hydroxy-1H-indole-3-yl)-2-oxo-3H-pyrrol-3-ylidene)-1,3-dihydro-2H-indole-2-one

C20H13N3O3 (343.0957)


A member of the class of hydroxyindoles resulting from the formal oxidative coupling between the 3-position of 1,3-dihydro-2H-indol-2-one and the 3-position of 1,3-dihydro-2H-pyrrol-2-one, which is substituted at the 5 position by a 5-hydroxy-1H-indol-3-yl group, where the newly-formed double bond has E configuration. It is a purple chromobacterial pigment that has antibacterial, antifungal, antiprotozoan, and anticancer properties.

   

Caffeoyl tyrosine

2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoate

C18H17NO6 (343.1056)


Caffeoyl tyrosine is a constituent of cocoa flowers and robusta coffee beans [CCD]

   

DHBOA-Glc

7-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


Constituent of the roots of Coix lachryma-jobi (Jobs tears). (R)-2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one 2-glucoside is found in tea, alcoholic beverages, and coffee and coffee products. DHBOA-Glc is found in alcoholic beverages. DHBOA-Glc is a constituent of the roots of Coix lachryma-jobi (Jobs tears).

   

p-Coumaroyl 3-hydroxytyrosine

3-(3,4-Dihydroxyphenyl)-2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propanoate

C18H17NO6 (343.1056)


p-Coumaroyl 3-hydroxytyrosine is a constituent of the bark of Dalbergia melanoxylon [CCD]

   

Avenanthramide 1s

2-{[(2E)-1-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C18H17NO6 (343.1056)


Avenanthramide 1s is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

N-desmethylrosiglitazone

4-hydroxy-5-[(4-{2-[(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-2,5-dihydro-1,3-thiazol-2-one

C17H17N3O3S (343.0991)


N-desmethylrosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)

   

HHPAA glucuronide

(2S,3S,4S,5R,6S)-6-{2-[(1,2-dihydroxyethylidene)amino]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylate

C14H17NO9 (343.0903)


2-Hydroxy-N-(2-hydroxyphenyl)acetamide glucuronide (HHPAA glucuronide) is a benzoxazinoid metabolite. It is a potential urinary biomarker of whole grain intake (PMID: 23681766).

   

Clothiapine

13-chloro-10-(4-methylpiperazin-1-yl)-2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene

C18H18ClN3S (343.091)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clothiapine, an atypical antipsychotic agent, shares with clozapine its strong antiserotonergic properties[1].

   

Violacein

(3E)-3-(1,2-Dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene)-1,3-dihydro-2H-indol-2-one

C20H13N3O3 (343.0957)


   

DHBOA hexose

(2R)-7-hydroxy-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


   

Toddaliopsin C

Toddaliopsin C

C18H17NO6 (343.1056)


   

Hyrtiosulawesine

Hyrtiosulawesine

C20H13N3O3 (343.0957)


   
   

Auxarconjugatin A

Auxarconjugatin A

C19H18ClNO3 (343.0975)


   

6-methoxytecleanthine

6-methoxytecleanthine

C18H17NO6 (343.1056)


   

coryternatine C

coryternatine C

C18H17NO6 (343.1056)


   

6-Hydroxy blepharin

6-Hydroxy blepharin

C14H17NO9 (343.0903)


   

6,9-dihydroxystaurosporinone

6,9-dihydroxystaurosporinone

C20H13N3O3 (343.0957)


   

pestalamide A

pestalamide A

C18H17NO6 (343.1056)


A pyranone that is (2S)-2-methyl-4-oxo-4-{[(4-oxo-4H-pyran-3-yl)carbonyl]amino}butanoic acid substituted by a benzyl group at position 6. It has been isolated from Aspergillus niger.

   

(2R)-2-O-beta-D-glucopyranosyl-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one|(2R)-2-O-??-D-Glucopyranosyl-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one

(2R)-2-O-beta-D-glucopyranosyl-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one|(2R)-2-O-??-D-Glucopyranosyl-5-hydroxy-2H-1,4-benzoxazin-3(4H)-one

C14H17NO9 (343.0903)


   

Tensidol B

Tensidol B

C18H17NO6 (343.1056)


A furopyrrole that is tensidol A in which the hydroxy group attached to the pyrrole ring has been acylated by formal condensation with the 4-carboxy group of 2-methylbutanedioic acid.

   

(1E,3Z,5E,7E)-auxarconjugatin A

(1E,3Z,5E,7E)-auxarconjugatin A

C19H18ClNO3 (343.0975)


   

Xenocladoniamide C

Xenocladoniamide C

C20H13N3O3 (343.0957)


   

3-[[4-(1H-Indol-3-yl)-5-oxo-1,5-dihydro-2H-pyrrol]-2-ylidene]-5-hydroxy-1,3-dihydro-2H-indol-2-one

3-[[4-(1H-Indol-3-yl)-5-oxo-1,5-dihydro-2H-pyrrol]-2-ylidene]-5-hydroxy-1,3-dihydro-2H-indol-2-one

C20H13N3O3 (343.0957)


   

(+)-10,11-dioxoerythratine

(+)-10,11-dioxoerythratine

C18H17NO6 (343.1056)


   

5-Methoxyneoamphimedine

5-Methoxyneoamphimedine

C20H13N3O3 (343.0957)


   

bromopride

bromopride

C14H22BrN3O2 (343.0895)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Bromopride is a dopamine antagonist with prokinetic properties, widely used as an antiemetic.

   

(-)-N-[4-Hydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine

(-)-N-[4-Hydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine

C18H17NO6 (343.1056)


   

Caffeoyl-N-tyrosine

Caffeoyl-N-tyrosine

C18H17NO6 (343.1056)


   

C14H17NO9_(2S)-4-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside

NCGC00385947-01_C14H17NO9_(2S)-4-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside

C14H17NO9 (343.0903)


   

C14H17NO9_(2S)-7-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside

NCGC00385507-01_C14H17NO9_(2S)-7-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside

C14H17NO9 (343.0903)


   

DIBOA + O-Hex

DIBOA + O-Hex

C14H17NO9 (343.0903)


Annotation level-3

   

3,4-DAA

2-[3-(3,4-dimethoxy-phenyl)-acryloylamino]-3-hydroxy-benzoic acid

C18H17NO6 (343.1056)


   

Avenanthramide 1s

2-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enamido]benzoic acid

C18H17NO6 (343.1056)


   

Deoxyclovamide

2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enamido]-3-(4-hydroxyphenyl)propanoic acid

C18H17NO6 (343.1056)


   

p-Coumaroyl 3-hydroxytyrosine

3-(3,4-dihydroxyphenyl)-2-[3-(4-hydroxyphenyl)prop-2-enamido]propanoic acid

C18H17NO6 (343.1056)


   

DIBOA-Glc

4-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


   

DHBOA-Glc

7-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


   

Fmoc-D-Cys-OH.H2O

Fmoc-D-Cys-OH.H2O

C18H17NO4S (343.0878)


   

1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine

1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine

C13H18ClN5O4 (343.1047)


   

Picoprazole

Picoprazole

C17H17N3O3S (343.0991)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor

   

N-pyridin-2-yl-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide

N-pyridin-2-yl-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide

C18H12F3N3O (343.0932)


   

N-pyridin-2-yl-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide

N-pyridin-2-yl-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide

C18H12F3N3O (343.0932)


   

4 5-DIHYDRO-3-(4-PYRIDINYL)-2H-BENZ(G)-INDAZOLE METHANESULFONATE

4 5-DIHYDRO-3-(4-PYRIDINYL)-2H-BENZ(G)-INDAZOLE METHANESULFONATE

C17H17N3O3S (343.0991)


   

3-CHLORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

3-CHLORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

C19H18ClNO3 (343.0975)


   

((2R,3S)-3-((Benzyloxy)methyl)oxiran-2-yl)methyl 4-nitrobenzoate

((2R,3S)-3-((Benzyloxy)methyl)oxiran-2-yl)methyl 4-nitrobenzoate

C18H17NO6 (343.1056)


   

(E)-ethyl 3-(cyclopropylamino)-2-(2,4,5- trifluoro-3-methoxybenzoyl)acrylate

(E)-ethyl 3-(cyclopropylamino)-2-(2,4,5- trifluoro-3-methoxybenzoyl)acrylate

C16H16F3NO4 (343.1031)


   

6-Methoxy-1-phenyl-3-(trifluoromethyl)-1H-pyrazolo[3,4-b] quinoline

6-Methoxy-1-phenyl-3-(trifluoromethyl)-1H-pyrazolo[3,4-b] quinoline

C18H12F3N3O (343.0932)


   

N,N-dimethyl-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-7-sulfonamide

N,N-dimethyl-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-7-sulfonamide

C17H17N3O3S (343.0991)


   

[(2S,3S)-2-(4-methoxyphenyl)-4-oxo-3,5-dihydro-2H-1,5-benzothiazepin-3-yl] acetate

[(2S,3S)-2-(4-methoxyphenyl)-4-oxo-3,5-dihydro-2H-1,5-benzothiazepin-3-yl] acetate

C18H17NO4S (343.0878)


   

2-chloro-4-(biphenyl-3-yl)-6-phenyl-1,3,5-triazine

2-chloro-4-(biphenyl-3-yl)-6-phenyl-1,3,5-triazine

C21H14ClN3 (343.0876)


   

2-chloro-4-(biphenyl-4-yl)-6-phenyl-1,3,5-triazine

2-chloro-4-(biphenyl-4-yl)-6-phenyl-1,3,5-triazine

C21H14ClN3 (343.0876)


   

2-[1,1-Biphenyl]-2-yl-4-chloro-6-phenyl-1,3,5-triazine

2-[1,1-Biphenyl]-2-yl-4-chloro-6-phenyl-1,3,5-triazine

C21H14ClN3 (343.0876)


   

2-(1-Adamantyl)isoquinolinium bromide

2-(1-Adamantyl)isoquinolinium bromide

C19H22BrN (343.0936)


   

ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate

ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate

C18H17NO4S (343.0878)


   

1,3,3a,4,6,6a-hexahydroimidazo[4,5-d]imidazole-2,5-dione,formaldehyde,N-methylbenzenesulfonamide

1,3,3a,4,6,6a-hexahydroimidazo[4,5-d]imidazole-2,5-dione,formaldehyde,N-methylbenzenesulfonamide

C12H17N5O5S (343.095)


   

4-(4-CHLOROPHENYL)-2,2:6,2-TERPYRIDINE

4-(4-CHLOROPHENYL)-2,2:6,2-TERPYRIDINE

C21H14ClN3 (343.0876)


   

N-Desmethyl Rosiglitazone

N-Desmethyl Rosiglitazone

C17H17N3O3S (343.0991)


   

1-(3-Nitrophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

1-(3-Nitrophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

C18H17NO6 (343.1056)


   

3-[3-(1,3-Dioxo-2-benzo[de]isoquinolinyl)propylthio]propanoic acid

3-[3-(1,3-Dioxo-2-benzo[de]isoquinolinyl)propylthio]propanoic acid

C18H17NO4S (343.0878)


   
   

Clotiapine

Clothiapine

C18H18ClN3S (343.091)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clothiapine, an atypical antipsychotic agent, shares with clozapine its strong antiserotonergic properties[1].

   

Diboa-glucoside

(2R)-4-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside

C14H17NO9 (343.0903)


   

(2S)-6-carboxy-4-[(E)-2-(5,6-dihydroxy-2,3-dihydroindol-1-yl)ethenyl]-2,3-dihydropyridine-2-carboxylate

(2S)-6-carboxy-4-[(E)-2-(5,6-dihydroxy-2,3-dihydroindol-1-yl)ethenyl]-2,3-dihydropyridine-2-carboxylate

C17H15N2O6- (343.093)


   

HHPAA glucuronide

HHPAA glucuronide

C14H17NO9 (343.0903)


   

DIBOA beta-D-glucoside

DIBOA beta-D-glucoside

C14H17NO9 (343.0903)


   

1-(4-Phenoxyphenyl)tetrahydro-1H-thieno[3,4-b]pyrrol-2(3H)-one 5,5-dioxide

1-(4-Phenoxyphenyl)tetrahydro-1H-thieno[3,4-b]pyrrol-2(3H)-one 5,5-dioxide

C18H17NO4S (343.0878)


   

8-(1-Piperidinylsulfonyl)-6-pyrido[1,2-a]quinazolinone

8-(1-Piperidinylsulfonyl)-6-pyrido[1,2-a]quinazolinone

C17H17N3O3S (343.0991)


   

N-Coumaroyl-3-hydroxytyrosine

N-Coumaroyl-3-hydroxytyrosine

C18H17NO6 (343.1056)


   

2-Amino-3-[hydroxy-(2-hydroxy-3-pentanoyloxypropoxy)phosphoryl]oxypropanoic acid

2-Amino-3-[hydroxy-(2-hydroxy-3-pentanoyloxypropoxy)phosphoryl]oxypropanoic acid

C11H22NO9P (343.1032)


   

Caffeoyl tyrosine

Caffeoyl tyrosine

C18H17NO6 (343.1056)


   
   

6-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2,3-dihydroxybenzoic acid

6-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2,3-dihydroxybenzoic acid

C18H17NO6 (343.1056)


   

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C18H17NO6 (343.1056)


   

(2s,3r,4s,5s,6r)-2-{[(2s)-3,6-dihydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-3,6-dihydroxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO9 (343.0903)


   

5-hydroxy-3-(6-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)pyrrol-2-one

5-hydroxy-3-(6-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)pyrrol-2-one

C20H13N3O3 (343.0957)


   

5-(6-amino-2-hydroxy-3-methyl-5,8-dioxonaphthalen-1-yl)-2,4-dimethyl-5-oxopent-3-enoic acid

5-(6-amino-2-hydroxy-3-methyl-5,8-dioxonaphthalen-1-yl)-2,4-dimethyl-5-oxopent-3-enoic acid

C18H17NO6 (343.1056)


   

3-[(6-benzyl-4-oxopyran-3-carbonyl)-c-hydroxycarbonimidoyl]-2-methylpropanoic acid

3-[(6-benzyl-4-oxopyran-3-carbonyl)-c-hydroxycarbonimidoyl]-2-methylpropanoic acid

C18H17NO6 (343.1056)


   

10-acetyl-4-(1-aminoethylidene)-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraene-3,5-dione

10-acetyl-4-(1-aminoethylidene)-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraene-3,5-dione

C18H17NO6 (343.1056)


   

3-{5-hydroxy-4-[(3e)-2-hydroxyindol-3-ylidene]pyrrol-2-yl}-1h-indol-5-ol

3-{5-hydroxy-4-[(3e)-2-hydroxyindol-3-ylidene]pyrrol-2-yl}-1h-indol-5-ol

C20H13N3O3 (343.0957)


   

3-(3,4-dihydroxyphenyl)-2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propanoic acid

3-(3,4-dihydroxyphenyl)-2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propanoic acid

C18H17NO6 (343.1056)


   

(1s,18r,19r)-18-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene-11,12-dione

(1s,18r,19r)-18-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene-11,12-dione

C18H17NO6 (343.1056)


   

2,4-dihydroxy-1,4-benzoxazin-3-one-2-o-β-d-glucopyranoside

NA

C14H17NO9 (343.0903)


{"Ingredient_id": "HBIN004312","Ingredient_name": "2,4-dihydroxy-1,4-benzoxazin-3-one-2-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C14H17NO9","Ingredient_Smile": "C1=CC=C2C(=C1)N(C(=O)C(O2)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r)-2-o-β-d-glucopyranosyl-5-hydroxy-2h-1,4-benzoxazin-3(4h)-one

NA

C14H17NO9 (343.0903)


{"Ingredient_id": "HBIN006384","Ingredient_name": "(2r)-2-o-\u03b2-d-glucopyranosyl-5-hydroxy-2h-1,4-benzoxazin-3(4h)-one","Alias": "NA","Ingredient_formula": "C14H17NO9","Ingredient_Smile": "C1=CC=C2C(=C1)N(C(=O)C(O2)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8665","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-hydroxy blepharin

NA

C14H17NO9 (343.0903)


{"Ingredient_id": "HBIN012420","Ingredient_name": "6-hydroxy blepharin","Alias": "NA","Ingredient_formula": "C14H17NO9","Ingredient_Smile": "C1=CC2=C(C=C1O)NC(=O)C(O2)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9857","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s)-2-amino-3-(4-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}phenyl)propanoic acid

(2s)-2-amino-3-(4-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}phenyl)propanoic acid

C18H17NO6 (343.1056)


   

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12,14-triol

3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12,14-triol

C20H13N3O3 (343.0957)


   

(2r,6s)-3-hydroxy-16-oxa-4,14,22-triazahexacyclo[15.6.1.0²,⁶.0⁷,¹⁵.0⁸,¹³.0²¹,²⁴]tetracosa-1(23),3,7(15),8,10,12,17(24),18,20-nonaen-5-one

(2r,6s)-3-hydroxy-16-oxa-4,14,22-triazahexacyclo[15.6.1.0²,⁶.0⁷,¹⁵.0⁸,¹³.0²¹,²⁴]tetracosa-1(23),3,7(15),8,10,12,17(24),18,20-nonaen-5-one

C20H13N3O3 (343.0957)


   

6-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dihydroxybenzoic acid

6-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dihydroxybenzoic acid

C18H17NO6 (343.1056)


   

(2r,4e)-10-acetyl-4-(1-aminoethylidene)-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraene-3,5-dione

(2r,4e)-10-acetyl-4-(1-aminoethylidene)-11,13-dihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),6,10,12-tetraene-3,5-dione

C18H17NO6 (343.1056)


   

(2s)-3-[(6-benzyl-4-oxopyran-3-carbonyl)-c-hydroxycarbonimidoyl]-2-methylpropanoic acid

(2s)-3-[(6-benzyl-4-oxopyran-3-carbonyl)-c-hydroxycarbonimidoyl]-2-methylpropanoic acid

C18H17NO6 (343.1056)


   

(2s)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propanoic acid

(2s)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propanoic acid

C18H17NO6 (343.1056)


   

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C18H17NO6 (343.1056)


   

6-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dihydroxybenzoic acid

6-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dihydroxybenzoic acid

C18H17NO6 (343.1056)


   

(2s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C18H17NO6 (343.1056)


   

3-{6-hydroxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-5-ol

3-{6-hydroxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-5-ol

C20H13N3O3 (343.0957)


   

diboa β-d-glucoside

diboa β-d-glucoside

C14H17NO9 (343.0903)


   

18-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene-11,12-dione

18-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraene-11,12-dione

C18H17NO6 (343.1056)


   

3-{5-hydroxy-4-[(3z)-2-hydroxyindol-3-ylidene]pyrrol-2-yl}-1h-indol-5-ol

3-{5-hydroxy-4-[(3z)-2-hydroxyindol-3-ylidene]pyrrol-2-yl}-1h-indol-5-ol

C20H13N3O3 (343.0957)


   

(1-hydroxy-2,3-dimethoxy-9-oxoacridin-10-yl)methyl acetate

(1-hydroxy-2,3-dimethoxy-9-oxoacridin-10-yl)methyl acetate

C18H17NO6 (343.1056)


   

2-[(3,6-dihydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3,6-dihydroxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C14H17NO9 (343.0903)


   

(2s)-2-amino-3-{2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-4-hydroxyphenyl}propanoic acid

(2s)-2-amino-3-{2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-4-hydroxyphenyl}propanoic acid

C18H17NO6 (343.1056)


   

6-[8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-4-methoxy-3-methylpyran-2-one

6-[8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-4-methoxy-3-methylpyran-2-one

C19H18ClNO3 (343.0975)


   

(2r)-4-hydroxy-2-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,4-benzoxazin-3-one

(2r)-4-hydroxy-2-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-1,4-benzoxazin-3-one

C14H17NO9 (343.0903)


   

6-[(1e,3z,5e,7e)-8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-5-methoxy-4-methylpyran-2-one

6-[(1e,3z,5e,7e)-8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-5-methoxy-4-methylpyran-2-one

C19H18ClNO3 (343.0975)


   

(2s,3e)-5-(6-amino-2-hydroxy-3-methyl-5,8-dioxonaphthalen-1-yl)-2,4-dimethyl-5-oxopent-3-enoic acid

(2s,3e)-5-(6-amino-2-hydroxy-3-methyl-5,8-dioxonaphthalen-1-yl)-2,4-dimethyl-5-oxopent-3-enoic acid

C18H17NO6 (343.1056)


   

3-[5-(5-hydroxy-1h-indol-3-yl)-2-oxo-1h-pyrrol-3-ylidene]-1h-indol-2-one

3-[5-(5-hydroxy-1h-indol-3-yl)-2-oxo-1h-pyrrol-3-ylidene]-1h-indol-2-one

C20H13N3O3 (343.0957)


   

6,7,11-trimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

6,7,11-trimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

C18H17NO6 (343.1056)


   

6-[(1e,3e,5e,7e)-8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-4-methoxy-3-methylpyran-2-one

6-[(1e,3e,5e,7e)-8-(3-chloro-1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]-4-methoxy-3-methylpyran-2-one

C19H18ClNO3 (343.0975)